ABTI
ALTEROLA BIOTECH INC.Company Information
- Company Name
- ALTEROLA BIOTECH INC.
- CIK
- CIK0001442999
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ABTI: OTC
- Fiscal Year End
- March 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2833
- SIC Description
- Medicinal Chemicals & Botanical Products
- Ticker
- ABTI
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2024-11-29
- Price on filing date
- —
- 1-month reaction
- -40.00%
- 3-month reaction
- -28.00%
Balance Sheet
Values in millions ($)| Line item | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Funds Held Under Reinsurance Agreements Asset | - | - | - | - | - | - | - | 0 | - | - | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Value Added Tax Receivable | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Deferred Income Tax Assets Net | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 1 | - | - | - | - | - | - | - | - | - | - | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Assets Noncurrent | ||||||||||||||||||
| Deferred Offering Costs | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Intangible Assets Current | 0 | - | - | - | 0 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | ||||||
| Deferred Costs | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 1 | 1 | 0 | 0 | 0 | 13 | 12 | 12 | 12 | 12 | 12 | 12 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accrued Liabilities And Other Liabilities | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Liabilities | ||||||||||||||||||
| Notes Payable | 2 | 1 | - | - | - | - | - | - | - | - | - | - | ||||||
| Convertible Notes Payable Current | 0 | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Liabilities Noncurrent | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 4 | 2 | 1 | 1 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Due To Related Parties Current And Noncurrent | - | - | - | - | - | - | - | 1 | 0 | 0 | 0 | 0 | ||||||
| Other Accrued Liabilities Current | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Loans Payable Current | 0 | 0 | 0 | 0 | 2 | 1 | 1 | - | 0 | 0 | 0 | - | ||||||
| Liabilities | 4 | 2 | 1 | 1 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Commitments And Contingencies | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Value | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Treasury Stock Common Value | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 10 | 10 | 10 | 10 | 8 | 20 | 19 | 19 | 19 | 18 | 18 | 15 | ||||||
| Stockholders Equity | -2 | -1 | -1 | -1 | -2 | 10 | 10 | 10 | 11 | 11 | 11 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -14 | -13 | -12 | -12 | -10 | -10 | -10 | -10 | -9 | -8 | -8 | -5 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax | -0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | ||||||
| Minority Interest In Joint Ventures | - | -0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Minority Interest | -0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities And Stockholders Equity | 1 | 0 | 0 | 0 | 0 | 13 | 12 | 12 | 12 | 12 | 12 | 12 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | - | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | - | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | - | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | ||||||
| Treasury Stock Common Shares | - | - | - | - | 29 | - | - | - | - | - | - | - | ||||||
| Common Stock Shares Issued | 1,467 | 1,467 | - | 1,383 | 778 | 807 | - | 807 | 807 | 803 | 803 | 786 | ||||||
| Shares Outstanding | 1,467 | 1,467 | 1,383 | 1,383 | 778 | 807 | 807 | 807 | 807 | 803 | 803 | 786 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialALTEROLA BIOTECH INC. (ABTI) — SEC Financial Statements & Analysis
ALTEROLA BIOTECH INC. (ABTI) is a medicinal chemicals & botanical products company. ALTEROLA BIOTECH INC. trades on OTC as: ABTI. ALTEROLA BIOTECH INC. (ABTI)'s most recent SEC filing is a Form 10-Q for the period ended 2024-09-30, filed with the SEC on 2024-11-29. Based on that filing, ALTEROLA BIOTECH INC. carries a market cap of $5.87M, a P/E ratio of -2.47x, a P/B ratio of -2.61x, an enterprise value of $8.14M, and an EV/EBITDA multiple of -3.86x. On profitability, it posts a Return on Equity (ROE) of 109.62%, a Return on Assets (ROA) of -255.13%, and a Return on Invested Capital (ROIC) of -20.75%. Per share, it reports EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 14.64% year-over-year and EPS growth of -39.22% year-over-year. On the balance sheet, it maintains a current ratio of 0.32x, a quick ratio of 0.32x, working capital of $-2.47M, a debt-to-equity ratio of -1.61x, a debt ratio of 2.65, an interest coverage ratio of -6.25x, free cash flow of $-1.45M (TTM), and net debt of $2.27M. Figures sourced from SEC EDGAR.
- Market Cap
- $5.87M
- P/E TTM
- -2.47x
- EPS TTM
- $-0.00
- P/B TTM
- -2.61x
- ROE TTM
- 109.62%
- ROA TTM
- -255.13%
- Debt To Equity
- -1.61x
- Free Cash Flow TTM
- $-1.45M
Data as of 2024-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ALTEROLA BIOTECH INC. in?
ALTEROLA BIOTECH INC. (ABTI) operates in the Medicinal Chemicals & Botanical Products industry.
What exchange does ABTI trade on?
ALTEROLA BIOTECH INC. (ABTI) trades on the OTC.
When was ALTEROLA BIOTECH INC. (ABTI)'s most recent SEC filing?
ALTEROLA BIOTECH INC. (ABTI)'s most recent SEC filing is a Form 10-Q for the period ended 2024-09-30, filed with the SEC on 2024-11-29.
What is ABTI's market cap?
ALTEROLA BIOTECH INC. (ABTI) has a market capitalization of $5.87M as of 2024-09-30.
What is ABTI's EPS (earnings per share)?
ALTEROLA BIOTECH INC. (ABTI)'s trailing twelve month EPS is $-0.00 as of 2024-09-30.
What is ABTI's ROE (return on equity)?
ALTEROLA BIOTECH INC. (ABTI)'s trailing twelve month Return on Equity (ROE) is 109.62% as of 2024-09-30.
What is ABTI's ROA (return on assets)?
ALTEROLA BIOTECH INC. (ABTI)'s trailing twelve month Return on Assets (ROA) is -255.13% as of 2024-09-30.
What is ABTI's ROIC (return on invested capital)?
ALTEROLA BIOTECH INC. (ABTI)'s trailing twelve month Return on Invested Capital (ROIC) is -20.75% as of 2023-06-30.
What is ABTI's EV/EBITDA?
ALTEROLA BIOTECH INC. (ABTI)'s trailing twelve month EV/EBITDA is -3.86x as of 2024-09-30.